Loading…
Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells
Overexpression/amplification of human epidermal growth factor receptor (HER)2/neu (erbB-2) oncogene plays a causal role in carcinogenesis and correlates with a poor clinical prognosis. However, little is known about HER2 in gastric cancer. In this study, we explored the pharmacological activities of...
Saved in:
| Published in: | Biological & Pharmaceutical Bulletin 2010/06/01, Vol.33(6), pp.931-937 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3 |
| container_end_page | 937 |
| container_issue | 6 |
| container_start_page | 931 |
| container_title | Biological & Pharmaceutical Bulletin |
| container_volume | 33 |
| creator | Lee, Myung Sun Cha, Eun Young Thuong, Phuong Thien Kim, Ji Yeon Ahn, Moon Sang Sul, Ji Young |
| description | Overexpression/amplification of human epidermal growth factor receptor (HER)2/neu (erbB-2) oncogene plays a causal role in carcinogenesis and correlates with a poor clinical prognosis. However, little is known about HER2 in gastric cancer. In this study, we explored the pharmacological activities of natural triterpenoid corosolic acid (CRA) in HER2 signaling and its role in gastric cancer development and progression. In this study, CRA dramatically inhibited HER2 expression in a dose- and time-dependent manner, effectively inhibited cell proliferation, and induced G0/G1 arrest through the induction of p27kip1 and cyclin D1 down-regulation. CRA exposure enhanced apoptotic cell death, as confirmed by caspase-3 and poly (ADP-ribose) polymerase cleavage activities. CRA inhibited signaling pathways downstream of HER2, including phospho-proteins such as Akt and Erk. In addition, CRA combined with adriamycin and 5-fluorouracil enhanced this growth inhibition, but not with docetaxel and paclitaxel. These findings demonstrate that CRA suppresses HER2 expression, which in turn promotes cell cycle arrest and apoptotic cell death of gastric cancer cells, providing a rationale for future clinical trials of CRA in the treatment of HER2-positive gastric cancers. |
| doi_str_mv | 10.1248/bpb.33.931 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907156758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907156758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3</originalsourceid><addsrcrecordid>eNqFkdFq2zAUhs3YWLNuN3uAIdhFYeBUR7Ik-2oEr00DpYWyXRtZklMFR_Ikm5I32mNOWZIWerMbSaDvfOdIf5Z9BjwHUpSX7dDOKZ1XFN5kM6CFyBkB9jab4QrKnAMrz7IPMW4wxgIT-j47I5gRUjE2y_788E8ufzDrqZej9Q75Dt1MW-nQ1WC1CVvZo2XwT-MjupZq9AE9GGWG_YFcOjOhe6f82jiD2h2qffDR91ahhbIarZyelImoNn2P6p3qDVqEYOKIpNNoMfikiTYi69BdvcrvSnFsvZRxDMlSS6dM-FcfP2bvOtlH8-m4n2e_rq9-1jf57f1yVS9ucyWgGnNouZGkK0GBAWDUaKMF4V2lWwmScc5BFaQgWCugWkmtVak7yTvCWEGUpOfZxcE7BP97SsM2WxtVmkA646fYVFgA44KV_yUFpcCAckjk11fkxk_BpWc0UBQVFYIznKhvB0qlX4zBdM0Q7FaGXQO42QfdpKAbSpsUdIK_HJVTuzX6GT0lm4DlAUi3Vsneu94689JYRdFa3_tUkfQYU4p52qDBSb9fBGBesnJv-n4wbeIo1-a5lQyjTZmepuKHZV99ulGPMjTG0b_gldC_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449377650</pqid></control><display><type>article</type><title>Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells</title><source>Free Full-Text Journals in Chemistry</source><creator>Lee, Myung Sun ; Cha, Eun Young ; Thuong, Phuong Thien ; Kim, Ji Yeon ; Ahn, Moon Sang ; Sul, Ji Young</creator><creatorcontrib>Lee, Myung Sun ; Cha, Eun Young ; Thuong, Phuong Thien ; Kim, Ji Yeon ; Ahn, Moon Sang ; Sul, Ji Young ; Chungnam National University School of Medicine ; Chungnam National University Hospital ; cDepartment of Surgery and Research Institute for Medicinal Sciences ; aRegional Cancer Institute ; bVietnam National Institute of Medicinal Materials</creatorcontrib><description>Overexpression/amplification of human epidermal growth factor receptor (HER)2/neu (erbB-2) oncogene plays a causal role in carcinogenesis and correlates with a poor clinical prognosis. However, little is known about HER2 in gastric cancer. In this study, we explored the pharmacological activities of natural triterpenoid corosolic acid (CRA) in HER2 signaling and its role in gastric cancer development and progression. In this study, CRA dramatically inhibited HER2 expression in a dose- and time-dependent manner, effectively inhibited cell proliferation, and induced G0/G1 arrest through the induction of p27kip1 and cyclin D1 down-regulation. CRA exposure enhanced apoptotic cell death, as confirmed by caspase-3 and poly (ADP-ribose) polymerase cleavage activities. CRA inhibited signaling pathways downstream of HER2, including phospho-proteins such as Akt and Erk. In addition, CRA combined with adriamycin and 5-fluorouracil enhanced this growth inhibition, but not with docetaxel and paclitaxel. These findings demonstrate that CRA suppresses HER2 expression, which in turn promotes cell cycle arrest and apoptotic cell death of gastric cancer cells, providing a rationale for future clinical trials of CRA in the treatment of HER2-positive gastric cancers.</description><identifier>ISSN: 0918-6158</identifier><identifier>ISSN: 1347-5215</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.33.931</identifier><identifier>PMID: 20522955</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Antineoplastic Agents, Phytogenic - pharmacology ; Antineoplastic Agents, Phytogenic - therapeutic use ; Apoptosis - drug effects ; Caspase 3 - metabolism ; Cell Cycle - drug effects ; Cell Line, Tumor ; Cell Proliferation - drug effects ; corosolic acid ; Dose-Response Relationship, Drug ; Down-Regulation ; gastric cancer ; Gene Expression - drug effects ; Genes, erbB-2 ; human epidermal growth factor receptor 2/neu ; Humans ; Phytotherapy ; Plant Extracts - pharmacology ; Plant Extracts - therapeutic use ; Poly(ADP-ribose) Polymerases - metabolism ; Receptor, ErbB-2 - genetics ; Receptor, ErbB-2 - metabolism ; Signal Transduction - drug effects ; Stomach Neoplasms - drug therapy ; Triterpenes - pharmacology ; Triterpenes - therapeutic use</subject><ispartof>Biological and Pharmaceutical Bulletin, 2010/06/01, Vol.33(6), pp.931-937</ispartof><rights>2010 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3</citedby><cites>FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20522955$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Myung Sun</creatorcontrib><creatorcontrib>Cha, Eun Young</creatorcontrib><creatorcontrib>Thuong, Phuong Thien</creatorcontrib><creatorcontrib>Kim, Ji Yeon</creatorcontrib><creatorcontrib>Ahn, Moon Sang</creatorcontrib><creatorcontrib>Sul, Ji Young</creatorcontrib><creatorcontrib>Chungnam National University School of Medicine</creatorcontrib><creatorcontrib>Chungnam National University Hospital</creatorcontrib><creatorcontrib>cDepartment of Surgery and Research Institute for Medicinal Sciences</creatorcontrib><creatorcontrib>aRegional Cancer Institute</creatorcontrib><creatorcontrib>bVietnam National Institute of Medicinal Materials</creatorcontrib><title>Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells</title><title>Biological & Pharmaceutical Bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Overexpression/amplification of human epidermal growth factor receptor (HER)2/neu (erbB-2) oncogene plays a causal role in carcinogenesis and correlates with a poor clinical prognosis. However, little is known about HER2 in gastric cancer. In this study, we explored the pharmacological activities of natural triterpenoid corosolic acid (CRA) in HER2 signaling and its role in gastric cancer development and progression. In this study, CRA dramatically inhibited HER2 expression in a dose- and time-dependent manner, effectively inhibited cell proliferation, and induced G0/G1 arrest through the induction of p27kip1 and cyclin D1 down-regulation. CRA exposure enhanced apoptotic cell death, as confirmed by caspase-3 and poly (ADP-ribose) polymerase cleavage activities. CRA inhibited signaling pathways downstream of HER2, including phospho-proteins such as Akt and Erk. In addition, CRA combined with adriamycin and 5-fluorouracil enhanced this growth inhibition, but not with docetaxel and paclitaxel. These findings demonstrate that CRA suppresses HER2 expression, which in turn promotes cell cycle arrest and apoptotic cell death of gastric cancer cells, providing a rationale for future clinical trials of CRA in the treatment of HER2-positive gastric cancers.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Antineoplastic Agents, Phytogenic - therapeutic use</subject><subject>Apoptosis - drug effects</subject><subject>Caspase 3 - metabolism</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>corosolic acid</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation</subject><subject>gastric cancer</subject><subject>Gene Expression - drug effects</subject><subject>Genes, erbB-2</subject><subject>human epidermal growth factor receptor 2/neu</subject><subject>Humans</subject><subject>Phytotherapy</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Extracts - therapeutic use</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptor, ErbB-2 - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Triterpenes - pharmacology</subject><subject>Triterpenes - therapeutic use</subject><issn>0918-6158</issn><issn>1347-5215</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkdFq2zAUhs3YWLNuN3uAIdhFYeBUR7Ik-2oEr00DpYWyXRtZklMFR_Ikm5I32mNOWZIWerMbSaDvfOdIf5Z9BjwHUpSX7dDOKZ1XFN5kM6CFyBkB9jab4QrKnAMrz7IPMW4wxgIT-j47I5gRUjE2y_788E8ufzDrqZej9Q75Dt1MW-nQ1WC1CVvZo2XwT-MjupZq9AE9GGWG_YFcOjOhe6f82jiD2h2qffDR91ahhbIarZyelImoNn2P6p3qDVqEYOKIpNNoMfikiTYi69BdvcrvSnFsvZRxDMlSS6dM-FcfP2bvOtlH8-m4n2e_rq9-1jf57f1yVS9ucyWgGnNouZGkK0GBAWDUaKMF4V2lWwmScc5BFaQgWCugWkmtVak7yTvCWEGUpOfZxcE7BP97SsM2WxtVmkA646fYVFgA44KV_yUFpcCAckjk11fkxk_BpWc0UBQVFYIznKhvB0qlX4zBdM0Q7FaGXQO42QfdpKAbSpsUdIK_HJVTuzX6GT0lm4DlAUi3Vsneu94689JYRdFa3_tUkfQYU4p52qDBSb9fBGBesnJv-n4wbeIo1-a5lQyjTZmepuKHZV99ulGPMjTG0b_gldC_</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Lee, Myung Sun</creator><creator>Cha, Eun Young</creator><creator>Thuong, Phuong Thien</creator><creator>Kim, Ji Yeon</creator><creator>Ahn, Moon Sang</creator><creator>Sul, Ji Young</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><scope>7TO</scope></search><sort><creationdate>2010</creationdate><title>Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells</title><author>Lee, Myung Sun ; Cha, Eun Young ; Thuong, Phuong Thien ; Kim, Ji Yeon ; Ahn, Moon Sang ; Sul, Ji Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Antineoplastic Agents, Phytogenic - therapeutic use</topic><topic>Apoptosis - drug effects</topic><topic>Caspase 3 - metabolism</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>corosolic acid</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation</topic><topic>gastric cancer</topic><topic>Gene Expression - drug effects</topic><topic>Genes, erbB-2</topic><topic>human epidermal growth factor receptor 2/neu</topic><topic>Humans</topic><topic>Phytotherapy</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Extracts - therapeutic use</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptor, ErbB-2 - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Triterpenes - pharmacology</topic><topic>Triterpenes - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Myung Sun</creatorcontrib><creatorcontrib>Cha, Eun Young</creatorcontrib><creatorcontrib>Thuong, Phuong Thien</creatorcontrib><creatorcontrib>Kim, Ji Yeon</creatorcontrib><creatorcontrib>Ahn, Moon Sang</creatorcontrib><creatorcontrib>Sul, Ji Young</creatorcontrib><creatorcontrib>Chungnam National University School of Medicine</creatorcontrib><creatorcontrib>Chungnam National University Hospital</creatorcontrib><creatorcontrib>cDepartment of Surgery and Research Institute for Medicinal Sciences</creatorcontrib><creatorcontrib>aRegional Cancer Institute</creatorcontrib><creatorcontrib>bVietnam National Institute of Medicinal Materials</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><jtitle>Biological & Pharmaceutical Bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Myung Sun</au><au>Cha, Eun Young</au><au>Thuong, Phuong Thien</au><au>Kim, Ji Yeon</au><au>Ahn, Moon Sang</au><au>Sul, Ji Young</au><aucorp>Chungnam National University School of Medicine</aucorp><aucorp>Chungnam National University Hospital</aucorp><aucorp>cDepartment of Surgery and Research Institute for Medicinal Sciences</aucorp><aucorp>aRegional Cancer Institute</aucorp><aucorp>bVietnam National Institute of Medicinal Materials</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells</atitle><jtitle>Biological & Pharmaceutical Bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2010</date><risdate>2010</risdate><volume>33</volume><issue>6</issue><spage>931</spage><epage>937</epage><pages>931-937</pages><issn>0918-6158</issn><issn>1347-5215</issn><eissn>1347-5215</eissn><abstract>Overexpression/amplification of human epidermal growth factor receptor (HER)2/neu (erbB-2) oncogene plays a causal role in carcinogenesis and correlates with a poor clinical prognosis. However, little is known about HER2 in gastric cancer. In this study, we explored the pharmacological activities of natural triterpenoid corosolic acid (CRA) in HER2 signaling and its role in gastric cancer development and progression. In this study, CRA dramatically inhibited HER2 expression in a dose- and time-dependent manner, effectively inhibited cell proliferation, and induced G0/G1 arrest through the induction of p27kip1 and cyclin D1 down-regulation. CRA exposure enhanced apoptotic cell death, as confirmed by caspase-3 and poly (ADP-ribose) polymerase cleavage activities. CRA inhibited signaling pathways downstream of HER2, including phospho-proteins such as Akt and Erk. In addition, CRA combined with adriamycin and 5-fluorouracil enhanced this growth inhibition, but not with docetaxel and paclitaxel. These findings demonstrate that CRA suppresses HER2 expression, which in turn promotes cell cycle arrest and apoptotic cell death of gastric cancer cells, providing a rationale for future clinical trials of CRA in the treatment of HER2-positive gastric cancers.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>20522955</pmid><doi>10.1248/bpb.33.931</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0918-6158 |
| ispartof | Biological and Pharmaceutical Bulletin, 2010/06/01, Vol.33(6), pp.931-937 |
| issn | 0918-6158 1347-5215 1347-5215 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_907156758 |
| source | Free Full-Text Journals in Chemistry |
| subjects | Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antineoplastic Agents, Phytogenic - pharmacology Antineoplastic Agents, Phytogenic - therapeutic use Apoptosis - drug effects Caspase 3 - metabolism Cell Cycle - drug effects Cell Line, Tumor Cell Proliferation - drug effects corosolic acid Dose-Response Relationship, Drug Down-Regulation gastric cancer Gene Expression - drug effects Genes, erbB-2 human epidermal growth factor receptor 2/neu Humans Phytotherapy Plant Extracts - pharmacology Plant Extracts - therapeutic use Poly(ADP-ribose) Polymerases - metabolism Receptor, ErbB-2 - genetics Receptor, ErbB-2 - metabolism Signal Transduction - drug effects Stomach Neoplasms - drug therapy Triterpenes - pharmacology Triterpenes - therapeutic use |
| title | Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A29%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Down-Regulation%20of%20Human%20Epidermal%20Growth%20Factor%20Receptor%202/neu%20Oncogene%20by%20Corosolic%20Acid%20Induces%20Cell%20Cycle%20Arrest%20and%20Apoptosis%20in%20NCI-N87%20Human%20Gastric%20Cancer%20Cells&rft.jtitle=Biological%20&%20Pharmaceutical%20Bulletin&rft.au=Lee,%20Myung%20Sun&rft.aucorp=Chungnam%20National%20University%20School%20of%20Medicine&rft.date=2010&rft.volume=33&rft.issue=6&rft.spage=931&rft.epage=937&rft.pages=931-937&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.33.931&rft_dat=%3Cproquest_cross%3E907156758%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c719t-1b6ea2f81c1e1153eded726f9dba1a56661c42420dc13dcaddc8dfa6f25542ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1449377650&rft_id=info:pmid/20522955&rfr_iscdi=true |